These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 28626533)

  • 21. Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256.
    Yang H; Yang C; Wang Y; Rhodes G; Robinson M; Cheng G; Qi X; Mo H; Tian Y; Pakdaman R; Sheng XC; Kim CU; Delaney WE
    Antivir Ther; 2017; 22(5):413-420. PubMed ID: 28106531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 2'-α-C-Methyl-2'-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus.
    Zeng D; Zhang R; Nie Q; Cao L; Shang L; Yin Z
    ACS Med Chem Lett; 2016 Dec; 7(12):1197-1201. PubMed ID: 27994763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-HCV determinant motif identification in pyranone carboxamide scaffold.
    Balaraju T; Konreddy AK; Parveen A; Toyama M; Ito W; Karampuri S; Baba M; Sharon A; Bal C
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5224-7. PubMed ID: 26483202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antiviral evaluation of 2',3'-dideoxy-2',3'-difluoro-D-arabinofuranosyl 2,6-disubstituted purine nucleosides.
    Schinazi RF; Sivets GG; Detorio MA; McBrayer TR; Whitaker T; Coats SJ; Amblard F
    Heterocycl Comm; 2015; 21(5):315-327. PubMed ID: 34316093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
    Weng L; Tian X; Gao Y; Watashi K; Shimotohno K; Wakita T; Kohara M; Toyoda T
    Biochim Biophys Acta; 2012 Dec; 1820(12):1886-92. PubMed ID: 22954804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6.
    Xu S; Doehle B; Rajyaguru S; Han B; Barauskas O; Feng J; Perry J; Dvory-Sobol H; Svarovskaia ES; Miller MD; Mo H
    Antivir Ther; 2017; 22(7):587-597. PubMed ID: 28248189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents.
    McGuigan C; Madela K; Aljarah M; Bourdin C; Arrica M; Barrett E; Jones S; Kolykhalov A; Bleiman B; Bryant KD; Ganguly B; Gorovits E; Henson G; Hunley D; Hutchins J; Muhammad J; Obikhod A; Patti J; Walters CR; Wang J; Vernachio J; Ramamurty CV; Battina SK; Chamberlain S
    J Med Chem; 2011 Dec; 54(24):8632-45. PubMed ID: 22039920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
    McGuigan C; Perrone P; Madela K; Neyts J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.
    Liang C; Rieder E; Hahm B; Jang SK; Paul A; Wimmer E
    Virology; 2005 Mar; 333(1):41-53. PubMed ID: 15708591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug.
    Tobias SC; Borch RF
    Mol Pharm; 2004; 1(2):112-6. PubMed ID: 15832507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of 4'-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2.
    Zheng Z; Groaz E; Snoeck R; De Jonghe S; Herdewijn P; Andrei G
    ACS Med Chem Lett; 2021 Jan; 12(1):88-92. PubMed ID: 33479570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
    Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
    J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.
    Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A
    Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis.
    Berliba E; Bogus M; Vanhoutte F; Berghmans PJ; Good SS; Moussa A; Pietropaolo K; Murphy RL; Zhou XJ; Sommadossi JP
    Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31570394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 1-methyl-5-(3-azido-2,3-dideoxy-beta-D-erythro-pentofuranosyl)uracil and 1-methyl-5-(3-azido-2,3-dideoxy-2-fluoro-beta-D-arabinofuranosyl)uracil. The C-nucleoside isostere of 3'-azido-3'-deoxythymidine and its 2'-"up"-fluoro analogue.
    Sochacka E; Nawrot B; Pankiewicz KW; Watanabe KA
    J Med Chem; 1990 Jul; 33(7):1995-9. PubMed ID: 2362280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.
    Andreev IA; Manvar D; Barreca ML; Belov DS; Basu A; Sweeney NL; Ratmanova NK; Lukyanenko ER; Manfroni G; Cecchetti V; Frick DN; Altieri A; Kaushik-Basu N; Kurkin AV
    Eur J Med Chem; 2015; 96():250-8. PubMed ID: 25890075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents.
    Nishimura G; Ikeda M; Mori K; Nakazawa T; Ariumi Y; Dansako H; Kato N
    Antiviral Res; 2009 Apr; 82(1):42-50. PubMed ID: 19428594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides.
    Sterzycki RZ; Ghazzouli I; Brankovan V; Martin JC; Mansuri MM
    J Med Chem; 1990 Aug; 33(8):2150-7. PubMed ID: 2165162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide Analogues.
    Konreddy AK; Toyama M; Ito W; Bal C; Baba M; Sharon A
    ACS Med Chem Lett; 2014 Mar; 5(3):259-63. PubMed ID: 24900815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.